Omega 3 Prescription Drug Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Omega 3 Prescription Drug study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Omega 3 Prescription Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Omega 3 Prescription Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vascepa Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Omega 3 Prescription Drug include Abbott, Amarin Pharmaceuticals Ireland Ltd., GSK plc (GlaxoSmithKline plc), Natrapharm, Inc. (Patriot Pharmaceutical Corp.), Viatris, Inc., Grupo Ferrer Internacional, S.A., Camber Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd. and Zydus Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Omega 3 Prescription Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Omega 3 Prescription Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Omega 3 Prescription Drug Market Segment Percentages, by Type, 2021 (%)
Vascepa
Lovaza
Others
Global Omega 3 Prescription Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Omega 3 Prescription Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Omega 3 Prescription Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Omega 3 Prescription Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Omega 3 Prescription Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Omega 3 Prescription Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Amarin Pharmaceuticals Ireland Ltd.
GSK plc (GlaxoSmithKline plc)
Natrapharm, Inc. (Patriot Pharmaceutical Corp.)
Viatris, Inc.
Grupo Ferrer Internacional, S.A.
Camber Pharmaceuticals, Inc.
Dr. Reddy’s Laboratories Ltd.
Zydus Group
Hikma Pharmaceuticals PLC
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Omega 3 Prescription Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Omega 3 Prescription Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Omega 3 Prescription Drug Overall Market Size
2.1 Global Omega 3 Prescription Drug Market Size: 2021 VS 2028
2.2 Global Omega 3 Prescription Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Omega 3 Prescription Drug Players in Global Market
3.2 Top Global Omega 3 Prescription Drug Companies Ranked by Revenue
3.3 Global Omega 3 Prescription Drug Revenue by Companies
3.4 Top 3 and Top 5 Omega 3 Prescription Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Omega 3 Prescription Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Omega 3 Prescription Drug Players in Global Market
3.6.1 List of Global Tier 1 Omega 3 Prescription Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Omega 3 Prescription Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Omega 3 Prescription Drug Market Size Markets, 2021 & 2028
4.1.2 Vascepa
4.1.3 Lovaza
4.1.4 Others
4.2 By Type - Global Omega 3 Prescription Drug Revenue & Forecasts
4.2.1 By Type - Global Omega 3 Prescription Drug Revenue, 2017-2022
4.2.2 By Type - Global Omega 3 Prescription Drug Revenue, 2023-2028
4.2.3 By Type - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Omega 3 Prescription Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Omega 3 Prescription Drug Revenue & Forecasts
5.2.1 By Application - Global Omega 3 Prescription Drug Revenue, 2017-2022
5.2.2 By Application - Global Omega 3 Prescription Drug Revenue, 2023-2028
5.2.3 By Application - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Omega 3 Prescription Drug Market Size, 2021 & 2028
6.2 By Region - Global Omega 3 Prescription Drug Revenue & Forecasts
6.2.1 By Region - Global Omega 3 Prescription Drug Revenue, 2017-2022
6.2.2 By Region - Global Omega 3 Prescription Drug Revenue, 2023-2028
6.2.3 By Region - Global Omega 3 Prescription Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Omega 3 Prescription Drug Revenue, 2017-2028
6.3.2 US Omega 3 Prescription Drug Market Size, 2017-2028
6.3.3 Canada Omega 3 Prescription Drug Market Size, 2017-2028
6.3.4 Mexico Omega 3 Prescription Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Omega 3 Prescription Drug Revenue, 2017-2028
6.4.2 Germany Omega 3 Prescription Drug Market Size, 2017-2028
6.4.3 France Omega 3 Prescription Drug Market Size, 2017-2028
6.4.4 U.K. Omega 3 Prescription Drug Market Size, 2017-2028
6.4.5 Italy Omega 3 Prescription Drug Market Size, 2017-2028
6.4.6 Russia Omega 3 Prescription Drug Market Size, 2017-2028
6.4.7 Nordic Countries Omega 3 Prescription Drug Market Size, 2017-2028
6.4.8 Benelux Omega 3 Prescription Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Omega 3 Prescription Drug Revenue, 2017-2028
6.5.2 China Omega 3 Prescription Drug Market Size, 2017-2028
6.5.3 Japan Omega 3 Prescription Drug Market Size, 2017-2028
6.5.4 South Korea Omega 3 Prescription Drug Market Size, 2017-2028
6.5.5 Southeast Asia Omega 3 Prescription Drug Market Size, 2017-2028
6.5.6 India Omega 3 Prescription Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Omega 3 Prescription Drug Revenue, 2017-2028
6.6.2 Brazil Omega 3 Prescription Drug Market Size, 2017-2028
6.6.3 Argentina Omega 3 Prescription Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Omega 3 Prescription Drug Revenue, 2017-2028
6.7.2 Turkey Omega 3 Prescription Drug Market Size, 2017-2028
6.7.3 Israel Omega 3 Prescription Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Omega 3 Prescription Drug Market Size, 2017-2028
6.7.5 UAE Omega 3 Prescription Drug Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Omega 3 Prescription Drug Major Product Offerings
7.1.4 Abbott Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Amarin Pharmaceuticals Ireland Ltd.
7.2.1 Amarin Pharmaceuticals Ireland Ltd. Corporate Summary
7.2.2 Amarin Pharmaceuticals Ireland Ltd. Business Overview
7.2.3 Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Major Product Offerings
7.2.4 Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.2.5 Amarin Pharmaceuticals Ireland Ltd. Key News
7.3 GSK plc (GlaxoSmithKline plc)
7.3.1 GSK plc (GlaxoSmithKline plc) Corporate Summary
7.3.2 GSK plc (GlaxoSmithKline plc) Business Overview
7.3.3 GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Major Product Offerings
7.3.4 GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.3.5 GSK plc (GlaxoSmithKline plc) Key News
7.4 Natrapharm, Inc. (Patriot Pharmaceutical Corp.)
7.4.1 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Corporate Summary
7.4.2 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Business Overview
7.4.3 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Major Product Offerings
7.4.4 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.4.5 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Key News
7.5 Viatris, Inc.
7.5.1 Viatris, Inc. Corporate Summary
7.5.2 Viatris, Inc. Business Overview
7.5.3 Viatris, Inc. Omega 3 Prescription Drug Major Product Offerings
7.5.4 Viatris, Inc. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.5.5 Viatris, Inc. Key News
7.6 Grupo Ferrer Internacional, S.A.
7.6.1 Grupo Ferrer Internacional, S.A. Corporate Summary
7.6.2 Grupo Ferrer Internacional, S.A. Business Overview
7.6.3 Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Major Product Offerings
7.6.4 Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.6.5 Grupo Ferrer Internacional, S.A. Key News
7.7 Camber Pharmaceuticals, Inc.
7.7.1 Camber Pharmaceuticals, Inc. Corporate Summary
7.7.2 Camber Pharmaceuticals, Inc. Business Overview
7.7.3 Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Major Product Offerings
7.7.4 Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.7.5 Camber Pharmaceuticals, Inc. Key News
7.8 Dr. Reddy’s Laboratories Ltd.
7.8.1 Dr. Reddy’s Laboratories Ltd. Corporate Summary
7.8.2 Dr. Reddy’s Laboratories Ltd. Business Overview
7.8.3 Dr. Reddy’s Laboratories Ltd. Omega 3 Prescription Drug Major Product Offerings
7.8.4 Dr. Reddy’s Laboratories Ltd. Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.8.5 Dr. Reddy’s Laboratories Ltd. Key News
7.9 Zydus Group
7.9.1 Zydus Group Corporate Summary
7.9.2 Zydus Group Business Overview
7.9.3 Zydus Group Omega 3 Prescription Drug Major Product Offerings
7.9.4 Zydus Group Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.9.5 Zydus Group Key News
7.10 Hikma Pharmaceuticals PLC
7.10.1 Hikma Pharmaceuticals PLC Corporate Summary
7.10.2 Hikma Pharmaceuticals PLC Business Overview
7.10.3 Hikma Pharmaceuticals PLC Omega 3 Prescription Drug Major Product Offerings
7.10.4 Hikma Pharmaceuticals PLC Omega 3 Prescription Drug Revenue in Global Market (2017-2022)
7.10.5 Hikma Pharmaceuticals PLC Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Omega 3 Prescription Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|